| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
20 companies
Florence Anthony A. Jr. is a 10% Owner at Savara Inc with holdings across 20 companies. Recent SEC Form 4 filings include 7 buys and 8 sells.
Estimated insider holdings value: $1571.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 207,100 | $11.11 | $2,300,881.00 | +19.0% | - | - | |
| Feb 9, 2026 | SGP Spyglass Pharma, Inc. | 10% Owner | Buy | 937,500 | $16.00 | $15,000,000.00 | +18.4% | - | - | |
| Oct 2, 2025 | NEUE Neuehealth, Inc. | Director, 10% Owner | Sale+OE | 4,195 | $6.75 | $28,316.25 | - | - | - | |
| Sep 16, 2024 | MBX Mbx Biosciences, Inc. | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Apr 22, 2024 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 17,857 | $56.00 | $999,992.00 | +1.7% | -29.2% | -76.1% | |
| Jul 17, 2023 | SVRA Savara Inc | 10% Owner | Buy | 333,333 | $3.00 | $999,999.00 | +1.4% | +11.8% | +58.0% | |
| Dec 21, 2022 | ACLX Arcellx, Inc. | 10% Owner | Sell | 179 | $30.74 | $5,501.96 | -100% | -3.4% | +67.0% | |
| May 3, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 1,952 | $10.06 | $19,640.44 | -100% | -10.5% | -17.0% | |
| Apr 11, 2022 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 3,580,526 | $1.90 | $6,802,999.40 | +46.0% | +31.2% | -32.7% | |
| Jan 31, 2022 | HOOD Robinhood Markets, Inc. | Director | Sell | 2,082 | $14.22 | $29,597.71 | -100% | -25.9% | -26.4% |